Business Wire

MURATA-MANUFACTURING

24.3.2021 04:02:13 CET | Business Wire | Press release

Share
Murata’s LiDAR Based System Provides Data to Traffic Monitoring Service

In April, Murata Manufacturing Co., Ltd. (TOKYO:6981) (ISIN:JP3914400001) will begin a service in Indonesia that will provide data from a traffic counter system mapping traffic volume via local service providers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005470/en/

The system developed by Murata uses LiDAR technology*1 which has superior environmental adaptability compared to cameras, for its main sensor in order to adapt to changing analytical conditions, such as rain or darkness. With high-precision sensing, the system can reliably generate not only traffic volume data, but also traffic data that classifies vehicle-type information, such as passenger cars and large vehicles. This enables strategic advertising tailored to the desired time frame and vehicle-type data, for example, by displaying ads for specific products for B2B targets during commuting hours. By mapping regional traffic volumes, the system is also expected to see increased use as reference data for city planning, such as for the construction of shopping malls in locations with significant traffic levels.

The data provision service based on this system will start in Indonesia and later expand to the ASEAN region including Thailand and Malaysia.

The president of Murata Manufacturing, Norio Nakajima, issued the following statement.
“As a comprehensive electronic components maker, Murata Manufacturing since its founding has created products to support our customers who work in communications. As the digital transformation*2 continues globally, we are striving to not only provide electronic components and devices as before, but also to develop new digital business, including the provision of sensing data that will contribute to concrete solutions. We are working on boosting the digital information infrastructure in Southeast Asia with this new system and will contribute to the development of data visualization and digital transformation in countries around the world.”

Characteristics of the Traffic Counter System

  • Uses LiDAR technology with high positioning performance as its sensor unit. Conducts stable measurements even under conditions such as rain and darkness, simultaneously capturing targets’ movement speed and volume, and classifying vehicles on the road.
  • In addition to predicting rain based on CO2 and atmospheric pressure sensors, digitizes environmental data of the roads.
  • Provides predictive rain data in pre-determined areas by analyzing environmental information.
  • Customizable sensor functions responsive to client needs based on housing design that ensures extensibility.
  • Creates a mesh network at a low cost.
  • Can be implemented into existing infrastructure such as streetlights and pedestrian bridges.
  • Provides analytical data via a dedicated cloud server.
  • Gathers road traffic and environmental data captured with installed sensors provides real-time data and data processed via original algorithms, on a dedicated cloud server.

For details, please watch this video about the traffic counter system .

*1 Technology that measures the distance to a target by shining a laser on it and capturing the reflected laser light with an optical unit.
*2 The transformation of society and people’s lives for the better through the spread of information technology

Murata in Brief

Murata Manufacturing Co., Ltd. is a worldwide leader in the design, manufacture and sale of ceramic-based passive electronic components & solutions, communication modules and power supply modules. Murata is committed to the development of advanced electronic materials and leading edge, multi-functional, high-density modules. The company has employees and manufacturing facilities throughout the world. For more information, visit Murata's website at www.murata.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye